What are the benefits and risks of different corticosteroid treatments delivered intravenously for the prevention of bronchopulmonary dysplasia in infants born prematurely?

Cochrane Library Podcasts

Cochrane द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री Cochrane या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।

1M ago 4:27

MP3•एपिसोड होम

The question of whether and how to treat preterm infants with postnatal corticosteroids for the management of bronchopulmonary dysplasia, which is a chronic lung problem due to prematurity, has been a neonatologist's quandary for decades. In August 2023, Cochrane Neonatal published a network meta-analysis on the use of postnatal corticosteroids for its prevention. In this podcast, Roger Soll of Cochrane Neonatal, talks with the lead author Susanne Hay, an attending neonatologist at Beth Israel Deaconess Medical Center in the US, about her team's work.

341 एपिसोडस

#Health Industry #Health Care #Science #Medicine #Cochrane Review #Cochrane #Systematic Reviews #In Evidencebased Health Care #Health and Well-Being